Gamgee Technologies has raised $4.0M in seed funding, with Founders Fund leading the round and participation from Celine Halioua, Steven Eidelman, Arash Ferdowsi, and Gokul Rajaram.
The YC S26 startup is building an AI-first genomics platform for personalized mRNA cancer vaccines, starting with dogs. Its closed-loop system connects tumor sequencing, computational target selection, patient-specific manufacturing, and clinical outcomes, allowing the platform to learn from each treated animal. The approach could offer a faster, more iterative path to refining cancer vaccine technology before moving into human applications.
.png&w=3840&q=75)















